If you’ve been on the fertility journey for a while, you may have come across a test called AMH — anti-Müllerian hormone. It’s one of the most frequently discussed markers in fertility evaluations for women over 35, and it can stir up a lot of questions and, sometimes, anxiety. Understanding what this hormone actually measures — and what it doesn’t — can help put results in a more useful context.
AMH is produced by small follicles in the ovaries, and it’s considered a reflection of a woman’s ovarian reserve, or the pool of eggs that remain. As women age, this number tends to decline naturally. But a single number on a lab report tells only part of the story, and interpreting it requires context that a healthcare provider is best positioned to offer.
This article explores what research currently shows about AMH, how it’s used in fertility assessments, and what women over 35 may want to discuss with their care teams.
What Research Shows About AMH as a Fertility Marker
According to research published via the National Institute of Child Health and Human Development, AMH levels decline progressively with age and reach very low or undetectable levels around menopause. Studies suggest that AMH may offer a reasonable estimate of ovarian reserve, though its ability to predict natural conception remains a subject of ongoing research.
Importantly, studies have shown that women with lower AMH levels still conceive naturally, and that AMH does not directly measure egg quality — only quantity. This distinction matters enormously when interpreting results.
Understanding What AMH Measures — and What It Doesn’t
AMH is often framed as a “fertility clock,” but that framing can be misleading. Here’s what current evidence suggests the test actually reflects:
Ovarian Reserve
AMH is closely correlated with the number of antral follicles visible on ultrasound, which together give an estimate of how many eggs remain. A lower number generally suggests fewer eggs remain, while a higher number suggests more. However, “fewer” doesn’t mean “none,” and many women with low AMH conceive successfully.
Response to Fertility Treatment
Where AMH tends to be most clinically useful is in predicting how a woman might respond to ovarian stimulation during IVF. Women with lower levels may produce fewer eggs during a retrieval cycle. This helps reproductive endocrinologists plan medication protocols — it’s a practical tool for treatment planning rather than a definitive fertility verdict.
What AMH Doesn’t Tell You
AMH does not measure egg quality, which is arguably the most important factor in successful conception, especially after 35. It also doesn’t predict whether a specific cycle will result in pregnancy, and it doesn’t account for other fertility factors such as uterine health, hormonal balance, or partner fertility.
For more on how age-related changes affect fertility broadly, our article on understanding fertility changes after 35 offers helpful context.
Normal Ranges and Age-Related Changes
AMH reference ranges vary by laboratory, but generally speaking, levels tend to decline from the mid-30s onward. What’s considered “normal” shifts with age — a level that would be low for a 28-year-old may be entirely expected for a 40-year-old.
Some fertility specialists note that AMH should always be interpreted alongside other markers — such as antral follicle count (AFC) and FSH levels — and within the broader clinical picture. A single test result in isolation rarely provides a complete assessment.
What to Discuss With Your Healthcare Provider
If you’ve had an AMH test or are considering one, it may be worth asking your healthcare provider or reproductive endocrinologist the following:
- How does my AMH level compare to typical ranges for my age?
- What do my other fertility markers (AFC, FSH, estradiol) suggest alongside this result?
- How might this affect our approach if I’m considering fertility treatment?
- What would you recommend as next steps given the full picture?
These conversations can help translate a lab number into something more actionable and personally meaningful. Fertility specialists are also well-positioned to discuss when a referral to a reproductive endocrinologist might be beneficial.
Frequently Asked Questions
Can I get pregnant with a low AMH level?
Research suggests that many women with lower AMH levels do conceive naturally or with fertility assistance. AMH reflects quantity of eggs remaining, not their quality, and pregnancy depends on a combination of factors. Discussing your individual circumstances with a reproductive endocrinologist can help clarify what your results mean for your specific situation.
Does AMH change over time?
AMH levels do decline with age as part of the natural reproductive aging process. Some research also suggests that short-term fluctuations may occur, though the overall trend is downward. If you’ve had one test at a particular time, a follow-up measurement may provide additional perspective.
Should I get an AMH test if I’m not yet trying to conceive?
This is a question worth exploring with your gynecologist or primary care provider. Some women find it useful for planning purposes, while others find that a low result creates unnecessary anxiety without providing actionable guidance. The value of testing depends considerably on individual circumstances and goals.
Is AMH testing covered by insurance?
Coverage varies widely by insurance plan and reason for testing. It’s worth contacting your insurance provider or healthcare team to understand what may or may not be covered in your situation.
Key Takeaways
- AMH is a marker of ovarian reserve (egg quantity), not egg quality or direct fertility prediction.
- Lower AMH levels are expected with age and do not preclude natural conception or fertility treatment success for many women.
- AMH is most useful when interpreted alongside other fertility markers and within a full clinical assessment.
- If you have questions about your AMH results, a reproductive endocrinologist can provide the most informed interpretation.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.